Detailed analysis of five NS2 mutants of the autonomous parvovirus minute virus of mice (MVMp) has revealed the following. At low multiplicities of infection, NS2 mutants killed NB324K cells as well as wild-type (wt) MVM did and grew to high titers, while in contrast they grew poorly and did not readily kill murine A9 cells. Following CaPO4 transfection of murine fibroblasts, NS2 mutant infectious clones generated approximately 10-fold less monomer replicative-form DNA than wt and no detectable progeny single-stranded DNA. On nonmurine semipermissive NB324K cells, however, these mutant plasmid clones generated near wt levels of all replicative DNA forms. After infection of highly synchronized murine fibroblasts by NS2 mutant virus at inputs equivalent to those of the wt, mutant monomer replicative-form DNA was decreased 5-to 10-fold compared with that of the wt, and progeny single-stranded DNA accumulation was decreased to an even greater extent. Both total and cytoplasmic NS2 mutant RNA was decreased, but the amount of total viral mRNA generated, relative to accumulated viral DNA in the same experiments, was similar to that seen in wt infection. The accumulation of virus-generated proteins was also decreased in NS2 mutant infection; however, the magnitude of this decrease, compared with that of wt infections, was significantly greater than the concomitant decrease in mutant-generated levels of accumulated cytoplasmic RNA, and this effect was most dramatic for VP2. There was no such disparity between the relative accumulation of mutant-generated RNA and protein in cells permissive for the growth of these mutants. These results suggest that translation of MVM viral RNA is specifically reduced in NS2 mutant infection of restrictive cells. Because the affected viral proteins are required for the efficient production of viral replicative DNA forms, these results reveal a fundamental, although perhaps not the only, role for NS2 in parvovirus infection.
inputs equivalent to those of the wt, mutant monomer replicative-form DNA was decreased 5-to 10-fold compared with that of the wt, and progeny single-stranded DNA accumulation was decreased to an even greater extent. Both total and cytoplasmic NS2 mutant RNA was decreased, but the amount of total viral mRNA generated, relative to accumulated viral DNA in the same experiments, was similar to that seen in wt infection. The accumulation of virus-generated proteins was also decreased in NS2 mutant infection; however, the magnitude of this decrease, compared with that of wt infections, was significantly greater than the concomitant decrease in mutant-generated levels of accumulated cytoplasmic RNA, and this effect was most dramatic for VP2. There was no such disparity between the relative accumulation of mutant-generated RNA and protein in cells permissive for the growth of these mutants. These results suggest that translation of MVM viral RNA is specifically reduced in NS2 mutant infection of restrictive cells. Because the affected viral proteins are required for the efficient production of viral replicative DNA forms, these results reveal a fundamental, although perhaps not the only, role for NS2 in parvovirus infection.
The small nonstructural protein NS2 of the autonomous parvovirus minute virus of mice (MVMp) is a 25-kDa phosphoprotein (9, 11, 14) encoded by the viral R2 mRNA (2, 9, 14, 19) which is generated from the P4 promoter (34) and spliced between nucleotides (nt) 514 and 1989 (9, 19, 34) (Fig. 1) . From its initiation at nt 260, until nt 514, NS2 is encoded in the same open reading frame (ORF 3) as the 83-kDa nonstructural protein, NS1, which is encoded by the P4-generated mRNA Ri (2, 11, 12) . After the large splice (nt 514 to 1989), translation of NS2 shifts to ORF 2 (11, 12) . Alternate splicing of the small intron of R2 results in three isoforms of NS2 that vary at their carboxyl termini (Fig. 1B ) (9, 19, 28) . All three isoforms of NS2 have a short half-life of less than 1 h (14, 42) . They are predominantly localized in the cytoplasm (9, 14) , and their phosphorylated forms are exclusively cytoplasmic (14) . During infection, NS2, as well as NS1, appears prior to generation of the viral R3 mRNAs which encode the capsid proteins (42) . Both nonstructural proteins reach substantial steady-state levels late in infection, although the capsid proteins predominate (13, 14) . The relative accumulated levels of NS1 and NS2 are determined by the regulation of splicing of the viral P4 products and differences in protein stabilities (13, 14) .
NS2 is required for virus growth in a host-range-dependent manner both in tissue culture, and in vivo. MVM NS2 mutants are restricted for growth in cultured murine cells, but grow productively in hamster, transformed rat, transformed monkey, and transformed human cell lines (8, 29) . In murine cells, mutant NS2-2018, which truncates NS2 just after the large splice, accumulates 5-to 10-fold less monomer replicative-form (mRF) DNA at 24 h postinfection (p.i.) and is even more deficient in its accumulation of progeny singlestranded DNA (29) . NS2 mutants are also unable to induce a productive infection in newborn mice (6) . Similarly, an Hi mutant that fails to produce NS2 is restricted for growth in Rat-2 cells but grows productively in cell lines derived from human, hamster, and canine tissue (24) . This mutant virus productively infects newborn hamsters, but in contrast to wild-type (wt) Hi it is not able to productively infect newborn rats (24) .
Semipermissive nonmurine cells support NS2 mutant DNA replication and virus production to various degrees (8, 29) , and this has permitted the generation of NS2 mutant viral stocks. The plaque morphology of an NS2 mutant virus on NB324K cells varies depending on the location of the mutation in the molecule (29) , suggesting that the NS2 mutant viruses may differentially affect the killing of semipermissive cells.
In situ hybridization to infected cell monolayers transferred onto nitrocellulose has shown that when equivalent amounts of MVM NS2 mutant and wt virus (as measured by single-stranded DNA content) are used to infect restrictive murine fibroblasts, they generate similar numbers of centers of replication (8, 29 [47] ) in relation to the viral RNAs and protein coding regions in this area. Rl, R2, and R3 are alternately spliced in this region; the major splicing pattern (M) joins nt 2280 to 2377, the minor splicing pattern (m) joins nt 2317 to 2399, and a rare splicing pattern (r) joins nt 2280 to 2399 (9, 19, 28) . Although NS1 terminates before the alternate splicing region, three isoforms of NS2 that vary at their carboxy termini as shown are generated (9, 14) .
progress over time as does that of the wt. This suggests that NS2 mutants are blocked after entry of the infectious particles into the nucleus.
Preliminary characterization of the defect of NS2 mutants in restrictive infections of cultured cells has identified deficiencies in steady-state levels of accumulated DNA replicative forms, especially progeny single-stranded DNA, and in the accumulation of viral proteins, especially the capsid proteins, late in infection (8, 24, 29) . In this report, we present a detailed analysis of the accumulation of viral gene products and progeny DNA in the same restrictive and semipermissive infections by five NS2 mutants. Our results demonstrate that in restrictive infections by NS2 mutants, in addition to deficiencies in the accumulation of viral replicative DNA forms, there is a marked deficiency in the generation of viral proteins, especially VP2, relative to the accumulated total and cytoplasmic viral RNA compared with that from wt infections. Since these proteins are required for the efficient production of viral replicative DNA forms (13) , the inability to efficiently translate viral mRNAs during infection is likely to be a fundamental defect of these mutants in restrictive cells, revealing a role for NS2 in parvovirus infection.
MATERIALS AND METHODS
Cell lines, viral stocks, and infections. Murine A92L (A9) fibroblasts (25) , simian virus 40-transformed human NB324K cells (43) , and DMN4A cells (a chemically transformed derivative of BHK cells) (4), were maintained and passaged as described previously (29, 42, 47) . NS2 mutant virus stocks of MVMp were generated after transfection of infectious clones and titers on NB324K cells were determined as described previously (29) . Mutant virus stocks were not passaged further in order to minimize the accumulation of revertants. Viral DNA, RNA, and protein, generated by NS2 mutant and wt MVMp infection, were collected at the same times within the same experiments for analysis. Differences in the accumulation of mutant DNA, RNA, and protein compared with wt DNA, RNA, and protein were individually assessed within the same experiment, and these differences were then compared. Several experiments were performed, and the average of these comparisons was determined. Highly synchronized A9 cells were prepared by an isoleucine-aphidicolin double-block protocol as previously described (10, 13, 17, 23, 33) , and viral products were analyzed 12 h after release of infected cultures into S phase. DNA replication assay. Mutant and wt viral replicative forms produced during highly synchronous viral infections, or after CaPO4 transfections, were analyzed by Southern analysis of total cell extracts, after equilibration of DNA samples, as described previously (8, 29, 47) .
Isolation, analysis, and quantitation of total and cytoplasmic RNA. Total and cytoplasmic RNA samples were isolated from infected A9 cultures by direct lysis with guanidine isothiocyanate followed by cesium chloride step-gradient ultracentrifugation (10, 42) . For isolation of cytoplasmic RNA, nuclei were first removed by low-speed centrifugation (42) . Northern (RNA) blot analysis, used to analyze total and cytoplasmic RNA from infected cells, was performed as described previously (34) . Equivalent amounts of total RNA were loaded on gels containing ethidium bromide, and transfer was monitored by densitometric scanning of photographic negatives of stained nitrocellulose filters. Values were adjusted as necessary to account for differences in transfer. RNase protection assays were performed on total and cytoplasmic RNA, in probe excess, as previously described (10, 42 R2 , and R3 that utilize the small-splice donor at either nt 2280 or nt 2317, as previously described (10, 42) . The percentages of Rl, R2, and R3 were calculated by quantifying the radiolabelled fragments on a Molecular Dynamics PhophorImager and adjusting for the number of radiolabelled nucleotides in each fragment.
Protein analysis. For labelling, infected A9, NB324K, or DMN4A cells (1.5 x 106/100-mm dish) were refed with 2 ml of methionine-minus and cysteine-minus Dulbecco's modi- (27) . Lysates were collected, brought to a final concentration of 1% SDS to lyse the nuclei, and then diluted to 0.5% SDS. Equivalent amounts (5 x 106 trichloroacetic acid-precipitable counts) were then immunoprecipitated as previously described (27) by using either monospecific anti-NS1 antibodies produced in rabbits in response to purified fusion proteins, generated in Escherichia coli from expression vectors kindly provided by Cotmore and Tattersall (12), or anti-capsid antibodies as previously described (42) . The immunoprecipitated pellet was resuspended in loading dye, boiled for 10 min, and loaded onto an SDS-polyacrylamide (10%) gel. Gels were fluorographed, exposed to film, and then quantitated on a Molecular Dynamics PhophorImager as described above.
Protein stability. A9 cells, labelled as described above for 0.5 h, were washed four times with phosphate-buffered saline after the 35S-containing media were removed and refed with Dulbecco's modified Eagle's medium plus 5% fetal calf serum plus 20-fold excess unlabelled methionine and cysteine (42) , after which duplicate plates were harvested hourly and immunoprecipitated as described above. The products were separated and analyzed by electrophoresis on SDS-polyacrylamide (10%) gels, also as described above. Measurement of cell growth and virus production. A9 and NB324K cells were parasynchronized by incubating the cells in isoleucine-minus media for approximately 48 h (23) . Cells were infected with equivalent amounts of NS2 mutant and wt virus, as determined by DNA content, at a wt MOI of 1. At daily intervals p.i., cells were harvested and counted. Viable cell numbers were determined by trypan blue exclusion. At each time point, virus was isolated from cell pellets and supernatants as previously described (29) and analyzed by plaque assay on either NB324K or A9 cells to determine virus production.
RESULTS
In order to characterize the role of the small nonstructural protein NS2 during parvovirus infection, mutants NS2-2018, NS2-2159, NS2-2268, and NS2-2381 were created by introducing translation termination mutations into the unique NS2 ORF (ORF 2), at the nucleotide positions designated (29) . These mutations truncate NS2 at various positions after the large splice without altering the other viral proteins (Fig.  1B) . Mutant Dfl8 has a 3-nt insertion at nt 2290, which introduces an isoleucine into NS2, immediately after the NS1 termination codon (47) . NS2-1989 destroys the largesplice acceptor site at nt 1989, preventing splicing to R2 and thus the generation of NS2. All of these mutants, except for NS2-2381, are restricted for growth in cultured murine cells, but grow productively in hamster, transformed rat, transformed monkey, and transformed human cell lines, thus permitting the generation of mutant virus stocks (8, 29) . NS2-2381, which leaves the minor isoforms of NS2 unaltered, has a wt host range (29) ; however, we were unable to generate NS2-2381 virus stocks that did not contain abundant amounts of deleted molecules. This mutant, therefore, was not included in further analysis.
Analysis of virus production and the cytotoxic effect of NS2 mutants. Initially, to more precisely examine the cytotoxicity and virus production in cultures of NS2 mutant-infected restrictive and semipermissive cells, the growth of parasynchronized A9 and NB324K cells was assayed for 7 days after infection, and virus production was measured at days 1 and 5 p.i. In murine A9 cells, NS2 mutant virus production was significantly decreased (Fig. 2A, bottom) . Therefore, as expected, the growth of these cells was not significantly affected by these mutants, whereas wt MVMp drastically decreased the viability of these cells, compared with the viability of the mock-infected control cells ( Fig. 2A, top) . Although all NS2 mutants lacked a detectable effect on the growth of A9 cells, the production of virus was dependent upon the location of the NS2 mutation; mutations which either terminate NS2 close to the carboxy termini (NS2-2268) or insert an amino acid in this region (Dfl8) produced significantly more virus in these cells than the other NS2 mutants. NS2-2018, NS2-2159, NS2-2268, and Dfi8 showed 75,000-, 67,000-, 7,500-, and 500-fold reductions, respectively, in production of virus 5 days p.i., compared with that of the wt MVMp virus ( Fig. 2A, bottom) .
In contrast, growth of NB324K cells was severely affected by NS2 mutant infections (Fig. 2B, top) . NS2-1989, NS2- 2018, and NS2-2159 were able to kill these cells at efficiencies approaching that of wt MVMp, while NS2-2268 and Dfl8 killed NB324K cells even more efficiently than the wt did. By 5 days p.i., NS2-2268 and Df18 had generated amounts of virus equivalent to or greater than those generated by the wt, while NS2-1989 (data not shown), NS2-2018, and NS2-2159 produced 40-to 200-fold less than the wt (Fig.  2B, bottom) . The difference in production of NS2 mutant virus at both days 1 and 5 p.i. was, in general, proportional to their cytotoxic effects on NB324K cells. This difference is also consistent with the sizes of plaques previously obtained with these mutants on NB324K cells; i.e., NS2-1989 and NS2-2018, which generated small plaques, produced much less virus on day 1 p.i., while NS2-2268, which generated plaques larger than those generated by the wt, produced higher levels of virus than the wt on day 1 p.i. NS2, therefore, is not required to achieve substantial levels of cell killing in cell lines permissive for the replication of these viruses. These results do not exclude the possibility, however, that NS2, when present, contributes to the cytotoxicity of MVM in these cells.
Analysis of the block to NS2 mutant replication in murine fibroblasts. We next examined the accumulation of progeny viral replicative DNA intermediates after CaPO4 transfection of infectious NS2 mutant plasmid clones. NS2-2018 and Dfl8 generated approximately 10-fold less mRF than the wt did and no detectable progeny single-stranded DNA after transfection of restrictive murine A9 fibroblasts (Fig. 3, left  panel) . After transfection of semipermissive NB324K cells, however, both mutants generated amounts of both mRF and progeny single-stranded DNA that were similar to those generated by the wt (Fig. 3, right panel) . Transfections with NS2-1989, NS2-2159, and NS2-2268 gave similar results (data not shown).
In situ hybridizations to infected cell monolayers have determined that infections of restrictive murine cells by NS2 mutants are blocked after virus enters the cell nucleus (8, 29) . To further characterize this block, we characterized the accumulation of NS2 mutant and wt DNA replicative forms, virus-specific RNAs, and viral proteins generated in the same infections of highly synchronized A9 murine fibroblasts. (11, 12) : all of the NS2 mutants tested were deficient for both mRF and single-stranded DNA progeny accumulation when compared with the wt (Fig. 4 ; Table 1 ). mRF accumulation averaged 3-to 10-fold less than that of the wt by 12 h postrelease (Table 1) , and the magnitude of the decrease was not correlated to the location of the mutation. The average increase in production of NS2 mutant progeny single-stranded DNA during infection, from input levels (t = 0) to t = 12 h, was approximately 10-fold less than the wt increase, although persistence of the input single-stranded DNA to various levels prevents this from being a quantitative evaluation.
(ii) Analysis of viral RNA accumulation in NS2 mutant infections of synchronized A9 cells. The accumulation of total and cytoplasmic RNA, from the same experiments described above, was also examined at 12 h postrelease by both Northern analysis (Fig. 5) and RNase protection assays. The average amount of total accumulated Rl generated in NS2-2159, NS2-2268, and Dfi8 infections was somewhat less than the amount of Ri generated by wt infection (Table 2) , whereas NS2-1989 (which cannot produce R2) and NS2-2018 exhibited even greater amounts of Ri than the wt did. The increased accumulated ratio of Ri relative to R2 in NS2-2018 infections is due to a cis-acting effect of the artificially introduced translation termination codon as previously described (30) . The average amount of accumulated total R3 RNA produced by NS2-1989 and NS2-2018 was one-to twofold less than that of the wt, respectively, while R3 accumulation for the remaining NS2 mutants was approximately threefold less than that of the wt ( Fig. 6; Table 3 ). NS2 mutants generated less viral protein in a 1-h pulse than the wt at the same point in infection ( Fig. 6 ; Table 3 ). The defect in NS1 production was two-to threefold lower than that of the wt, and VP1 production in NS2 mutant infections was reduced three-to fivefold compared with that of the wt (Table 3 ). The accumulation of the capsid protein VP2 during this time interval, however, was significantly more reduced than that of the other viral proteins-approximately 20-fold less, on average, than the accumulation of VP2 in wt infections (Table 3) . A similar decrease in mutant viral protein accumulation was also detected at 9 and 14 h postrelease (data not shown).
The reduction in the accumulation of NS2 mutant-generated protein during a 1-h pulse was significantly greater than the concomitant reduction in accumulated total or cytoplasmic RNA determined in the same experiment (Table 4; compare Fig. 5 and 6 ). The reduction in the level of NS2 mutant-generated NS1, compared with the wt level, was two-to fourfold greater than the reduction in either total or _ VP1
FIG. 6. Accumulation of NS2 mutant-generated NS1, VP1, and VP2 from infection of highly synchronized murine A9 cells. Proteins were labelled and isolated at the same time (12 h) from the same NS2 mutant and wt infections shown in Fig. 5 (42), suggesting that the decrease in the accumulated levels of VP2 during NS2 mutant infection is not due to a decrease in the stability of VP2.
The accumulation of NS2 mutant-generated proteins is similar to that of the wt in semipermissive cells. In contrast to infections of restrictive murine fibroblasts, the accumulation of NS2 mutant-generated protein, relative to viral RNA, was similar to or greater than that in wt MVM infections of semipermissive cells. At 12 h p.i. in synchronized NB324K cells and at 18 h p.i. in parasynchronized DMN4A cells, the amount of NS2 mutant-generated protein relative to accumulated viral RNA was within one-to twofold that of wt infections (Table 5 ). It was also apparent, for reasons not yet known, that the NS2 mutants generated a greater amount of RNA relative to accumulated mRF than the wt did in NB324K cells (data not shown).
DISCUSSION
Analyses of MVM and Hi mutants have previously shown that NS2 is required for both efficient DNA replication and virus production in a host-range-dependent manner, both in tissue culture and in animal models (8, 24, 29) . After transfection of murine fibroblasts, NS2 mutant infectious clones generate approximately 10-fold less replicative-form DNA than the wt does and generate no detectable progeny singlestranded DNA, whereas on more permissive NB324K cells, these mutants generate at least wt levels of all DNA forms. In situ hybridization to murine A9 cell monolayers infected with equal inputs of NS2-2018 and wt virus, as determined by DNA content, has shown that the block to NS2 mutants in restrictive cells occurs after the initiation of infection (8, 29) . A more detailed examination of this block in highly synchronized murine fibroblasts, presented in this report, has revealed that accumulation of mutant-generated mRF is decreased 3-to 10-fold compared with that of the wt after infection by five NS2 mutants at equivalent input levels. The accumulation of progeny single-stranded DNA in NS2 mutant infection, compared with that in wt infection, is reduced even more. Both total and cytoplasmic RNAs generated by NS2 mutants in restrictive infections are decreased, but the amount of RNA generated relative to the amount of accumulated DNA in the same experiments is similar to that of the wt. Previous results have shown that NS2 does not influence either the splicing or stability of MVM RNA (30); therefore, NS2 does not appear to play a significant role in viral transcription. The total amount of viral protein produced by the NS2 mutants is also decreased; however, the magnitude of this decrease, compared with the wt level, is significantly greater than the decrease in mutant levels of accumulated cytoplasmic RNA. These results suggest that a primary defect of NS2 mutants in restrictive cells is in the translation of viral RNA.
The translation of total cellular protein is not inhibited in NS2 mutant infections, suggesting that this effect is specific for MVM mRNA or includes, at most, a subset of cellular RNA. The basis for decreased translation of MVM mRNA in NS2 mutant infection is not known, but the following observations may be pertinent. First, RNA produced by NS2 mutants of parvovirus Hi in restrictive cells translates normally in reticulocyte lysates, indicating that there is nothing structurally altered in these molecules (24) . Second, in murine cell lines that stably express only the MVM capsid genes, R3 is translated efficiently (9, 22) , suggesting that perhaps the role of NS2 in murine cells is to counteract the effects, during infection, of the other viral nonstructural protein NS1. Finally, the dramatic defect in protein production relative to accumulated RNA is not evident when NS2 mutants are transfected into cells by using DEAE-dextran (data not shown). This latter observation suggests that perhaps, during NS2 mutant infections at low MOI, the localization of viral RNAs within the cytoplasm is aberrant. In perhaps a similar situation, the inefficient translation of (3, 15, 26) . Other viruses act to overcome the inhibition of translation brought about in infected cells by the action of interferon or in response to specific viral gene products. Adenovirus (20, 35, 40, 41, 44, 46) and vaccinia virus (32, 36, 48) , for instance, encode factors that inhibit the activation of the double-strand RNA-dependent eIF-2a kinase, whose phosphorylating activity reduces the activity of the translation factor eIF-2. These latter cases might suggest that the effect of MVM NS2 would be to counteract an inhibition of translation caused by MVM infection; however, we have not been able to detect a dramatic decrease in total cellular translation during short radioactive pulses in highly synchronized cells. Certainly the translation of an important subset of proteins could still be inhibited during wt MVM infections.
The disparity between viral protein and its encoding RNA is greatest for the capsid protein VP2. VP2 is encoded by R3 molecules that are spliced between nt 2280 and 2377 (Fig. 1) , which contain a long (695 nt) untranslated 5' leader sequence. Whether this long leader sequence, unique among MVM RNAs, mediates its response to NS2 during infection, requires a more detailed understanding of this process.
NS1 and VP2 have critical roles in viral DNA replication, suggesting that the decrease in VP2 and NS1 accumulation may be the primary defect of NS2 mutants, causing concomitant reductions in mRF and single-stranded DNA accumulation. Such speculation is supported by the observation that in permissive cells which support NS2 mutant replication, the ratios of mutant-generated protein and RNA accumulation are similar or greater than those for the wt. NS2 may, however, have additional roles required for viral replication.
Since all of the NS2 mutants are on average more defective for DNA replication after CaPO4 transfection than infection of A9 cells, although they generate roughly comparable levels of NS1, NS2 may also be involved in excision from the vector, a function likely related to a role in viral DNA replication. In addition, although all of the NS2 mutants show similar deficiencies in DNA replication after infection of A9 cells, there is a marked correlation between the location of the mutation and their ability to generate infectious virus on these cells. The dissociation of these phenotypes suggests an additional role for NS2 in the production of infectious virus, as previously proposed (24, 29) . Assessing the levels of complementation achieved by supplying capsid proteins in trans should help resolve these issues.
NS2 mutants at low MOI kill NB324K cells as well as the wt virus does and grow to high titers; in contrast, they do not readily affect the growth of murine A9 cells, in which they grow very poorly. Because mutant viral DNA replication and production of mutant viral proteins are reduced in restrictive murine fibroblasts, the failure to kill these cells cannot be directly attributable to the lack of a functional NS2, but previous results in which NS2 cDNAs were expressed in A9 cells from an inducible promoter have shown that NS2 has a cytotoxic effect on these cells (9) . NS2, however, is not required to achieve substantial levels of cell killing in cultures permissive for the replication of these mutants. The slight decrease, however, in the cytotoxicity of NS2-1989, NS2-2018, and NS2-2159 compared with wt cytotoxicity, as well as the enhanced cytotoxicity of NS2-2268 and Dfl8, implies that NS2 can participate in the killing of NB324K cells as well, as has been previously suggested by others (5, 7) . It is interesting that expression of NS2 proteins with truncated (NS2-2268) or altered (Dfl8) carboxy termini increases the cytotoxic effect of these viruses; perhaps NS2 contains a domain located in its carboxy terminus that limits the cytotoxicity of this protein.
